z-logo
open-access-imgOpen Access
The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus
Author(s) -
Ashley D. Frazier,
W. Scott Champney
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks182
Subject(s) - ribosome , ribosomal rna , ribonucleoside , staphylococcus aureus , protein subunit , ribosomal protein , biology , translation (biology) , antibiotics , antimicrobial , eukaryotic small ribosomal subunit , microbiology and biotechnology , biochemistry , bacteria , rna , genetics , messenger rna , gene
The discovery of new antibiotic targets is important to stem the increase in antibiotic resistance to most currently used antimicrobials. The bacterial ribosome is a major target for a large number of antibiotics that inhibit different aspects of translation. Most of these antimicrobial agents also inhibit ribosomal subunit formation as a second cellular target. Precise subunit assembly requires the activity of several distinct RNases for proper rRNA processing. The present work shows that the vanadyl ribonucleoside complex (VRC) inhibited RNases in Staphylococcus aureus involved in ribosomal subunit formation without an effect on translation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom